Key result
The study provides country-specific estimates of rotavirus gastroenteritis disease burden in children under 5 in CEVAG countries and offers evidence-based advice on rotavirus vaccination.
Provides country-specific estimates of rotavirus gastroenteritis burden and evidence-based advice on rotavirus vaccination in Central Europe.
May inform rotavirus vaccination planning in CEVAG countries; leaves open need for prospective validation before practice change.
Each year, rotavirus (RV) infection is the leading cause of acute gastroenteritis requiring hospitalisation and of nosocomially transmitted diseases in children younger than 5 years across Central European Vaccination Awareness Group (CEVAG) countries; however, inadequate surveillance systems and lack of routine RV testing still exist in most CEVAG countries, making it difficult to accurately assess the present burden of acute RV gastroenteritis in the younger population. Furthermore, routine immunisation of infants with RV vaccines has not been implemented, and no official and uniform recommendations exist in most of the countries in these territories. The present study provides CEVAG country-specific estimates of the disease burden of RV gastroenteritis among the youngest population and presents evidence-based advice on the use of RV vaccines in the region, while providing a framework for vaccination at the national level.
No takes yet. Share an insight, caveat, or question.
Mészner et al. (2013) conducted a review in Rotavirus gastroenteritis. Rotavirus vaccines was evaluated on Disease burden of rotavirus gastroenteritis. The study provides country-specific estimates of rotavirus gastroenteritis disease burden in children under 5 in CEVAG countries and offers evidence-based advice on rotavirus vaccination.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: